RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 164 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $23,000 | +4.5% | 20,000 | 0.0% | 0.02% | +60.0% |
| Q2 2022 | $22,000 | -62.7% | 20,000 | 0.0% | 0.01% | -69.7% |
| Q1 2022 | $59,000 | -77.7% | 20,000 | -80.0% | 0.03% | -76.6% |
| Q4 2021 | $265,000 | -27.0% | 100,000 | 0.0% | 0.14% | -11.9% |
| Q3 2021 | $363,000 | -16.4% | 100,000 | 0.0% | 0.16% | -34.4% |
| Q2 2021 | $434,000 | +26.9% | 100,000 | 0.0% | 0.24% | +10.9% |
| Q1 2021 | $342,000 | -13.4% | 100,000 | -11.5% | 0.22% | -25.9% |
| Q4 2020 | $395,000 | +45.8% | 113,000 | 0.0% | 0.30% | +32.0% |
| Q3 2020 | $271,000 | – | 113,000 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 1,500,000 | $1,620,000 | 1.72% |
| Soleus Capital Management, L.P. | 14,803,015 | $15,987,256 | 1.48% |
| ARMISTICE CAPITAL, LLC | 17,136,000 | $18,506,880 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,228,126 | $1,326,376 | 0.24% |
| GSA CAPITAL PARTNERS LLP | 971,441 | $1,049 | 0.09% |
| NJ State Employees Deferred Compensation Plan | 200,000 | $216,000 | 0.03% |
| Providence Wealth Advisors, LLC | 27,500 | $29,013 | 0.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,151,765 | $1,243,906 | 0.03% |
| XTX Topco Ltd | 164,238 | $177,377 | 0.03% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 3,369,076 | $3,638,602 | 0.02% |